Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2026-04-16 @ 2:50 PM
Study NCT ID:
NCT04984018
Status:
UNKNOWN
Last Update Posted:
2021-07-30
First Post:
2021-07-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Chidamide Plus Camrelizumab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade
Sponsor:
Organization: